The 3-year outcome of the PARTNER 2 (Placement of Aortic Transcatheter Valves 2) registry for valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) calls into question the significance of an isolated elevated… Click to show full abstract
The 3-year outcome of the PARTNER 2 (Placement of Aortic Transcatheter Valves 2) registry for valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) calls into question the significance of an isolated elevated trans-aortic valve (AV) mean gradient (MG) on echocardiography (ECHO) [(1)][1].
               
Click one of the above tabs to view related content.